Plain-English translation of NCT07672795 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial compares two approaches for treating a life-threatening type of stroke caused by a large clot blocking a major artery deep in the brain. Half of participants will receive emergency clot removal via a catheter (a thin tube threaded through blood vessels) plus standard stroke medications, while the other half will receive standard medications alone. The goal is to see which approach helps people recover better within 90 days.
This particular type of stroke (basilar artery occlusion with extensive brain damage) has historically had very poor outcomes, even with current treatments. Doctors want to know whether the invasive clot removal procedure—which carries its own risks—actually improves recovery compared to medication alone in patients with this severe form of stroke.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to either receive emergency clot removal surgery (plus standard stroke medications) or standard stroke medications alone. You will be treated in a hospital setting with imaging scans and neurological assessments at baseline. After treatment, you will return for follow-up visits and questionnaires at 90 days to assess your recovery, independence, quality of life, and any side effects. The entire active participation period lasts about 3 months.
AI-generated summary from trial data · Nov 18, 2026 · Not medical advice
China